{"id":55256,"date":"2025-02-06T11:34:18","date_gmt":"2025-02-06T11:34:18","guid":{"rendered":"https:\/\/www.innovationnewsnetwork.com\/?p=55256"},"modified":"2025-02-14T13:55:26","modified_gmt":"2025-02-14T13:55:26","slug":"clinical-testing-to-detect-canine-respiratory-diseases","status":"publish","type":"post","link":"https:\/\/www.innovationnewsnetwork.com\/clinical-testing-to-detect-canine-respiratory-diseases\/55256\/","title":{"rendered":"Clinical testing to detect canine respiratory diseases"},"content":{"rendered":"
As a result of the global COVID-19 pandemic, patients have grown to expect early detection and quick turn-around test results. Just as in human medicine, pet parents are no longer willing to wait to hear from a laboratory when bringing their dog or cat to the veterinary office. They expect almost immediate test results. This shift in patient expectations is what drives ControlPoint CEO Paula Walker.<\/p>\n
ControlPoint Inc. is an animal diagnostics company focused on developing tests that could be used by anyone, anywhere. Launched in 2020, ControlPoint is on a mission to improve the health and wellbeing of animals around the globe. Its initial product launch will offer a point-of-care test for canine infectious respiratory disease complex (CIRDC).<\/p>\n
Walker said: \u201cWhen pet health is at risk, fast, accurate testing and diagnoses are critical. ControlPoint will bring innovative new tools to veterinarians and others who care for pets.\u201d<\/p>\n
CIRDC, also known as kennel cough, is highly contagious, making early detection critical. All dog breeds and ages are susceptible. As the name \u2018kennel cough\u2019 suggests, dogs at particular risk are those exposed to settings where multiple dogs are typically gathered or housed, such as kennels, shelters, and daycare facilities. Several different types of bacteria and viruses can contribute to CIRDC, and dogs can be infected by two or more of these organisms at the same time.<\/p>\n Symptoms of kennel cough include a frequent honking cough, gagging, and retching and may involve froth that could last for weeks. It often becomes worse after exercise or activity, which can irritate the airways. Not all dogs may develop a cough. Other symptoms include runny nose and eyes or sneezing.<\/p>\n On-site veterinary testing for kennel cough has considerable advantages over laboratory-based testing, which usually involves laborious and expensive laboratory techniques and highly skilled personnel.\u00a0 All of the analytical processes involved in testing, from the sample collection to the communication of results, could be performed in a single step, considerably reducing the time between testing and treatment.\u00a0 Point-of-care testing can translate into more affordable veterinary care, reduced handling of animals, targeted treatments, and enable rapid diagnosis even in remote geographic areas.<\/p>\n ControlPoint\u2019s initial product offering to diagnose CIRCD could create a significant shift in disease diagnosis and treatment, providing test results within minutes. Current tests are expensive and can take weeks to get results. Market research has shown that 80% of veterinarians are interested in such a product. Additionally, 98% of pet parents will take their pets with clinical signs of CIRDC to a veterinarian, and more than 90% would opt for a point-of-care test on the same day of treatment, predicting a high adoption rate. ControlPoint has also received considerable market and product validation from its clinical partner, a shelter located in southern California.<\/p>\n Walker added: \u201cWe have an opportunity to ensure the lives and wellbeing of animals are greatly improved through the point-of-care tests we are currently developing. Seeing the product tested and making refinements is the next milestone in the exciting launch process.\u201d<\/p>\n To learn more, visit www.controlpointdx.com.<\/a><\/p>\nThe benefits of on-site testing<\/h3>\n